Edgewise Therapeutics (EWTX) is up 20.3%, or $4.41 to $26.16.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EWTX:
- Edgewise Therapeutics: Differentiated EDG-7500 Profile, Late-Stage Cardiology Catalyst, and Expanding Pipeline Support Buy Rating
- H.C. Wainwright says Edgewise data reinforces EDG-7500 potential differentiation
- Prolonged Safety Uncertainty and Eroding Differentiation Keep EDG-7500 at Hold
- Stifel says longer-term questions remain after Edgewise’s EDG-7500 update
- Edgewise Therapeutics rises 15.5%